Published in Infect Immun on September 01, 1997
Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev Mol Med (2008) 1.52
Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J Exp Med (2007) 1.39
Activation of the NLRP3 inflammasome by group B streptococci. J Immunol (2012) 1.25
Understanding Streptococcus suis serotype 2 infection in pigs through a transcriptional approach. BMC Genomics (2011) 1.06
Intracellular and extracellular cytokine production by human mixed mononuclear cells in response to group B streptococci. Infect Immun (2000) 1.03
Role of tumor necrosis factor alpha, interleukin-1beta, and interleukin-6 in a mouse model of group B streptococcal arthritis. Infect Immun (1999) 1.02
Interleukin-18 is an essential element in host resistance to experimental group B streptococcal disease in neonates. Infect Immun (2004) 0.92
Induction of T helper type 1 responses by a polysaccharide deacetylase from Cryptococcus neoformans. Infect Immun (2003) 0.87
Induction and termination of inflammatory signaling in group B streptococcal sepsis. Immunol Rev (2008) 0.84
Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis. Infect Immun (2013) 0.84
Essential role of interleukin-1 signaling in host defenses against group B streptococcus. MBio (2014) 0.84
Neutrophils Directly Recognize Group B Streptococci and Contribute to Interleukin-1β Production during Infection. PLoS One (2016) 0.79
Group B Streptococcus Induces a Robust IFN-γ Response by CD4(+) T Cells in an In Vitro and In Vivo Model. J Immunol Res (2016) 0.77
Neonatal Group B Streptococcal Disease in Otherwise Healthy Infants: Failure of Specific Neonatal Immune Responses. Front Immunol (2017) 0.75
Natural Killer Cell Functions during the Innate Immune Response to Pathogenic Streptococci. Front Microbiol (2017) 0.75
Group B Streptococci Induce Proinflammatory Responses via a Protein Kinase D1-Dependent Pathway. J Immunol (2017) 0.75
Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol (1995) 10.65
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med (1989) 10.60
Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med (1993) 8.76
Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med (1992) 8.27
Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med (1991) 7.52
Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med (1995) 6.89
Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med (1993) 5.75
Interleukin-12 and its role in the generation of TH1 cells. Immunol Today (1993) 5.55
Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol (1994) 4.86
Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma. J Immunol (1994) 3.50
IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol (1995) 3.29
Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med (1994) 2.99
The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis (1991) 2.35
IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J Immunol (1995) 2.12
Interleukin 12 in host defense against microbial pathogens. Proc Natl Acad Sci U S A (1993) 2.08
IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. J Immunol (1993) 2.01
Interleukin 12 induction of interferon gamma-dependent protection against malaria. Proc Natl Acad Sci U S A (1994) 1.77
IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J Immunol (1994) 1.75
Reduced interferon-gamma mRNA levels in human neonates. Evidence for an intrinsic T cell deficiency independent of other genes involved in T cell activation. J Exp Med (1986) 1.75
Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection. Infect Immun (1993) 1.56
Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc Natl Acad Sci U S A (1994) 1.47
Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob Agents Chemother (1994) 1.41
Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon. Infect Immun (1996) 1.30
IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J Immunol (1996) 1.23
Group B streptococcal infection in newborns: prevention at last? N Engl J Med (1986) 1.16
Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J Immunol (1996) 1.15
Beneficial effects of interleukin-6 in neonatal mouse models of group B streptococcal disease. Infect Immun (1994) 1.14
Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells. J Exp Med (1993) 1.12
Protection of mice from group A streptococcal skin infection by interleukin-12. J Infect Dis (1995) 1.12
Gamma interferon production in endotoxin-responder and -nonresponder mice during infection. Infect Immun (1991) 1.11
Interleukin-10 protects neonatal mice from lethal group B streptococcal infection. Infect Immun (1996) 1.06
Interleukin-12 and tumor necrosis factor alpha mediate innate production of gamma interferon by group B Streptococcus-treated splenocytes of severe combined immunodeficiency mice. Infect Immun (1996) 1.03
Role of gamma interferon in a neonatal mouse model of group B streptococcal disease. Infect Immun (1996) 0.97
Efficacy of tumor necrosis factor alpha and eicosanoid inhibitors in experimental models of neonatal sepsis. FEMS Immunol Med Microbiol (1994) 0.94
Neonatal hypersusceptibility to endotoxin correlates with increased tumor necrosis factor production in mice. J Infect Dis (1997) 0.92
Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J Immunol (2000) 2.49
Identification of gram-negative bacilli using the Autobac IDX. Diagn Microbiol Infect Dis (1985) 2.32
Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat Biotechnol (2000) 1.79
Evaluation of an automated, computerized system (automicrobic system) for Enterobacteriaceae identification. J Clin Microbiol (1981) 1.72
Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes. Nat Med (1998) 1.54
Pediatric peripheral blood progenitor cell collection: haemonetics MCS 3P versus COBE Spectra versus Fresenius AS104. Transfusion (1998) 1.44
Haemophagocytic syndrome in rheumatic patients. A systematic review. Eur Rev Med Pharmacol Sci (2012) 1.42
Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-kappaB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. J Immunol (1998) 1.34
Evaluation of a rapid method to exclude the presence of certain enteric pathogens in stool specimens. J Clin Microbiol (1984) 1.32
Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract (2003) 1.27
Detection of Arcobacter spp. in the coastal environment of the Mediterranean Sea. Appl Environ Microbiol (2004) 1.17
Secondary hemophagocytic lymphohistiocytosis in zoonoses. A systematic review. Eur Rev Med Pharmacol Sci (2012) 1.16
Mediation of Staphylococcus saprophyticus adherence to uroepithelial cells by lipoteichoic acid. Infect Immun (1987) 1.16
Group identification of streptococci. Evaluation of three rapid agglutination methods. Am J Clin Pathol (1981) 1.16
Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci. Infect Immun (1994) 1.16
Beneficial effects of interleukin-6 in neonatal mouse models of group B streptococcal disease. Infect Immun (1994) 1.14
Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components. Infect Immun (1997) 1.10
Interleukin-10 protects neonatal mice from lethal group B streptococcal infection. Infect Immun (1996) 1.06
Beta 2 integrins are involved in cytokine responses to whole Gram-positive bacteria. J Immunol (2000) 1.04
Anti-lipoteichoic acid antibodies enhance release of cytokines by monocytes sensitized with lipoteichoic acid. Infect Immun (1994) 1.04
[Anti-mycotic acitivity of pyocyanine in vitro and in vivo on a pathogenic strain of Candida albicans]. G Batteriol Virol Immunol Microbiol (1974) 1.02
Soluble antigens from group B streptococci induce cytokine production in human blood cultures. Infect Immun (1997) 1.01
Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer. Int J Gynecol Cancer (2008) 1.00
Role of IL-10 in a neonatal mouse listeriosis model. J Immunol (1999) 1.00
Tumor necrosis factor-inducing activities of Cryptococcus neoformans components. Infect Immun (1996) 1.00
Effects of HEMA on type I collagen protein in human gingival fibroblasts. Cell Biol Toxicol (2007) 0.99
Role of gamma interferon in a neonatal mouse model of group B streptococcal disease. Infect Immun (1996) 0.97
Immunocytochemical analysis of dentin: a double-labeling technique. J Biomed Mater Res A (2003) 0.95
Efficacy of tumor necrosis factor alpha and eicosanoid inhibitors in experimental models of neonatal sepsis. FEMS Immunol Med Microbiol (1994) 0.94
Neonatal hypersusceptibility to endotoxin correlates with increased tumor necrosis factor production in mice. J Infect Dis (1997) 0.92
Human monocyte receptors involved in tumor necrosis factor responses to group B streptococcal products. Infect Immun (2000) 0.91
Porins of Pseudomonas aeruginosa induce release of tumor necrosis factor alpha and interleukin-6 by human leukocytes. Infect Immun (1997) 0.88
Dentin matrix protein 1 and dentin sialophosphoprotein in human sound and carious teeth: an immunohistochemical and colorimetric assay. Eur J Histochem (2013) 0.86
Endotoxin-induced lethality in neonatal mice is counteracted by interleukin-10 (IL-10) and exacerbated by anti-IL-10. Clin Diagn Lab Immunol (1997) 0.85
Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13. Eur J Immunol (1997) 0.84
The role of endosomal toll-like receptors in bacterial recognition. Eur Rev Med Pharmacol Sci (2012) 0.82
Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer. Anticancer Res (2000) 0.81
G-CSF serum pharmacokinetics during peripheral blood progenitor cell mobilization: neutrophil count-adjusted dosage might potentially improve mobilization and be more cost-effective. Bone Marrow Transplant (1998) 0.81
Improved survival and antagonistic effect of sodium fusidate on tumor necrosis factor alpha in a neonatal mouse model of endotoxin shock. Antimicrob Agents Chemother (1996) 0.81
Factor VIIIR:Ag plasma levels in patients with cervical and ovarian carcinoma. Eur J Gynaecol Oncol (1988) 0.80
Secondary metabolites of Aspergillus exert immunobiological effects on human monocytes. Res Microbiol (1999) 0.80
Universal screening and intensive metabolic management of gestational diabetes: cost-effectiveness in Italy. Acta Diabetol (2002) 0.80
Laparoscopic removal of a giant paratubal cyst complicated by hydronephrosis. G Chir (2013) 0.80
Beneficial effects of antibacterial peptide PR-39 in a neonatal murine model of endotoxic shock. New Microbiol (2004) 0.79
Sjögren's syndrome: clinical, cytological, histological and colposcopic aspects in women. Clin Exp Obstet Gynecol (1988) 0.79
Plasma leptin levels in newborns from normal and diabetic mothers. Horm Metab Res (1998) 0.79
Streptococcal antibody tests in rheumatic fever. Ann Clin Lab Sci (1986) 0.79
Detection of group B streptococci by agglutination testing from selective broth cultures. Ann Clin Lab Sci (1985) 0.79
In vitro activities of new quinolones against Helicobacter pylori. Antimicrob Agents Chemother (1997) 0.79
Survival of a neglected case of brain abscess caused by Cladophialophora bantiana. Med Mycol (2006) 0.79
Recombinant Streptococcus gordonii for mucosal delivery of a scFv microbicidal antibody. Int Rev Immunol (2001) 0.78
Beta-lactam antibiotics (aztreonam, ampicillin, cefazolin and ceftazidime) in the control and eradication of Salmonella typhimurium in naturally resistant and susceptible mice. J Antimicrob Chemother (1990) 0.78
Characterization of an immunodominant epitope of small ruminant lentivirus (SRLV) nucleoprotein. Vet Immunol Immunopathol (2008) 0.77
Subclass specificity of the Fc receptor for human IgG on K562. Cell Immunol (1988) 0.77
RANK/RANKL/OPG signaling pathways in necrotic jaw bone from bisphosphonate-treated subjects. Eur J Histochem (2015) 0.77
Ovarian influence on adrenal androgen secretion in polycystic ovary syndrome. Fertil Steril (1995) 0.77
Synergic activities of streptococcal pyrogenic exotoxin A and lipoteichoic acid in cytokine induction. New Microbiol (2000) 0.76
The effect of a tyrosine kinase inhibitor on endotoxin mortality and splenocyte mediator production in the neonatal rat. Shock (1999) 0.76
Gelatin crosslinked with dehydroascorbic acid as a novel scaffold for tissue regeneration with simultaneous antitumor activity. Biomed Mater (2013) 0.76
Transforming growth factor beta 1 alters rat peritoneal macrophage mediator production and improves survival during endotoxic shock. Eur Cytokine Netw (1996) 0.76
Screening of gestational diabetes in Tuscany: results in 2000 cases. Ann Ist Super Sanita (1997) 0.76
Cytokine production in an ex vivo whole blood model following induction by group B streptococcal polysaccharides and lipoteichoic acid. Adv Exp Med Biol (1997) 0.76
Evaluation of the antifungal activity of fenticonazole on strains of Candida albicans on cellular lines. Mykosen (1985) 0.76
Effects of lithium carbonate on cytokine production in patients affected by breast cancer. J Biol Regul Homeost Agents (1995) 0.75
Evaluation of the central dopaminergic activity in gestational hyperprolactinaemia by means of the electroretinographic technique. Clin Exp Obstet Gynecol (1985) 0.75
Anti-idiotypic vaccination against group B streptococci. Int Rev Immunol (2001) 0.75
Age-related mortality and adherent splenic cell mediator production to endotoxin in the rat. Shock (1995) 0.75
Monocytes stimulated with group B streptococci or interferons release tumour necrosis factor-related apoptosis-inducing ligand. Scand J Immunol (2004) 0.75
The Crithidia luciliae and Farr assays for the detection of systemic lupus erythematosus. Ann Clin Lab Sci (1983) 0.75
Effect of nitric oxide donors and nitric oxide synthase inhibitors in neonatal rat endotoxic shock. Biochem Pharmacol (1999) 0.75
Redistribution of mouse spleen cell Fc receptors following treatment with mouse or human aggregated immunoglobulin G. J Reticuloendothel Soc (1983) 0.75
Relationship of vitamin A intake and E rosette inhibition to oral dysplasia and neoplasia. Cancer Detect Prev (1981) 0.75
[Usefulness of small dose insulin therapy in pregnant patients with potential and latent diabetes]. Minerva Ginecol (1977) 0.75
Colposcopy examination: not complementary but indispensable in preventing tumour pathology of the cervix. Eur J Gynaecol Oncol (1982) 0.75
Cytochalasin A inhibits B-lymphocyte capping and activation by antigens. Immunol Lett (1981) 0.75
Comparison of six systems for the identification of Enterobacteriaceae. G Batteriol Virol Immunol (1984) 0.75